CHARLOTTE, NC / ACCESSWIRE / July 6, 2018 / A 5-year multicenter study following focal therapy for prostate cancer, with the Sonablate HIFU technology, has been published and shows it is possible to ...

2025年4月26-29日，第120届美国泌尿外科学会年会（AUA 2025）在美国拉斯维加斯盛大举行。作为全球出席人数最多且极具影响力的泌尿领域学术会议，本届AUA汇聚了来自世界各地的泌尿外科医生、科研人员及行业人士，共同探讨泌尿疾病诊疗的前沿技术、临床实践与 ...

HIFIVE is a single arm, single institution, Phase I trial to assess the safety and performance of Sonablate high-intensity focused ultrasound for treating incompetent veins including vascular ...

SonaCare Medical has reported five-year outcomes from a study of focal therapy using its Sonablate high-intensity focused ultrasound (HIFU) system. The multicentre study included 625 patients with ...

CHARLOTTE, NC, UNITED STATES, June 21, 2023/EINPresswire.com/ -- Sonablate Corp., a global leader in minimally invasive focused ultrasound technologies, today ...

CHARLOTTE, N.C., July 9 USHIFU, LLC, a global leader innon invasive high intensity focused ultrasound (HIFU) technology, is proud toannounce sponsorship of the Sonablate(R) International HIFU Registry ...

CHARLOTTE, N.C., Oct. 28, 2024 (GLOBE NEWSWIRE) -- Sonablate Corp., current makers of the Sonablate HIFU system for prostate tissue ablation, today announced the first patient enrolled in the HIFIVE U ...